Camber Pharma Launches Generic Urocit-K®
Piscataway, NJ, April 8, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Potassium Citrate ER Tablets, which is the generic version of Urocit-K®
Potassium Citrate ER Tablets are used to treat a kidney stone condition called renal tubular acidosis.
Potassium Citrate ER Tablets are available from Camber in 5 mEq, 10mEq and 15 mEq – 100 count bottles.
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






